The efficacy ofthe PPARy antagonism in boosting IL-21 production is of major importance,considering IL-21 paucity during HIV infection [14, 15] and its documentedantiviral/immune-regulatory features [44-46, 56]. This evidence concerns the gene IL21 and HIV infectious disease.